Neurology Updates

Key clinical parameters, including stepwise progression, asymmetry, inflammatory markers, and neuroimaging (including ultrasound), can improve nerve…

Consensus-based recommendations issued by ECTRIMS and the EBMT on AHSCT use in MS and NMOSD

Recent studies demonstrated statistical plausibility of gene-disease associations in patients with focal lesional epilepsy. The identification of…

A meta-analysis comparing placebo-controlled trials in MG found a comparable effect of all innovative approaches, except for Rituximab, on the MG-ADL,…

This study explored the link between the evolution of consciousness and the advancement of the decannulation protocol in patients with prolonged…

Updated approach to GBS highlight its complexity and the need for broader approaches and personalized treatments to improve outcomes globally.

This is a summary of the paper titled “Trigeminal ganglion neurons are directly activated by influx of CSF solutes in a migraine model,” published in…

This paper explores the potential connection between hypocretin/orexin neurons in the lateral hypothalamus and epileptic seizures. To investigate this…

Biomarkers are currently rarely used as primary endpoint in clinical trials in neuromuscular diseases. Biomarkers can be divided into…

This open-label controlled study investigates the use of subcutaneous apomorphine for patients with prolonged disorders of consciousness. It suggests…

MS progression is linked to factors like vitamin D, EBV, obesity, and smoking. Targeting these with personalised care may slow progression and improve…

Neurological health disparities, driven by socioeconomic, racial and care inequities, impact outcomes in neurological diseases. Addressing these needs…